Researchers at UC Davis Health and the University of Texas Health Science Center at Houston (UTHealth Houston) are working on a new study to predict who is most at risk for dementia or Alzheimer’s disease. The study includes creating a health ‘scorecard’ for dementia risk. Here’s what you need to know about the study and how you can participate.
Study Goal
UT Health San Antonio will be the clinical research site for the Diverse Vascular Contributions to Cognitive Impairment and Dementia (Diverse VCID) study. Data will be collected through brain scans, genetics, and other key biomarkers. “Putting these very different pieces of information together, our ultimate goal is to really come up with a risk profile,” Dr. Charles DeCarli, Professor of Neurology and ...
Cuando una persona dona muestras biológicas o biospecímenes—sangre, líquido, o muestras de tejido—le da a los investigadores la oportunidad de entender, tratar y prevenir de una mejor manera, condiciones médicas desde el cáncer hasta el Alzheimer. Se necesitan de manera especial muestras biológicas de latinos, quienes sufren disparidades de salud. “Los latinos que donan muestras biológicas son héroes. Sus contribuciones permiten a los investigadores hacer descubrimientos médicos y crear terapias nuevas para ayudar a millones de latinos en todo el país”, dijo la Dra. Amelie G. Ramirez, líder de Salud America! programa latino de equidad en salud del Institute for Health Promotion Research en el Department of Population Health Sciences, de UT Health San ...
June is Alzheimer’s & Brain Awareness Month! This is a good time to reflect on the many challenges and inequities facing people of color in the United States when it comes to Alzheimer’s Disease, dementia, and brain health. Sadly, U.S. Latinos are 1.5 times more likely to develop Alzheimer’s disease than whites. Latino caregivers experience high levels of stress when supporting their family members with the disease. Let’s use #SaludTues on Tuesday, June 7, 2022, to tweet about the latest data, strategies, and programs to prevent and reduce Alzheimer’s disease and promote better brain health among Latinos and all people! WHAT: #SaludTues: How to Address Alzheimer’s in the Latino Community
TIME/DATE: 1-2 p.m. EST (Noon-1 p.m. CST), Tuesday, June 7, 2022
...
The National Institute of Aging (NIA) is seeking comments and suggestions on how it can implement community-based research networks to increase diversity in clinical trials for Alzheimer’s disease and related dementias (ADRD). At Salud America!, we believe that diverse representation is critical in Alzheimer's clinical trials to ensure that health and medical discoveries are equitable for diverse populations. This means increasing diversity among research leaders and clinical trial participants and establishing sustainable connections with Latino communities and other communities of color who have historically been underrepresented in medicine. If you agree, you can endorse Dr. Amelie Ramirez’s comment to NIA. Responses will be accepted through Saturday April 9, ...
Living with a cognitive disease is difficult because of how it impacts you and those around you. It can create a stigma, which prevents people from seeking help. This stigma can be worse for Latinos, who face cultural barriers and are often affected by these disorders at a high rate. That’s why physicians like Dr. Gus Alva are trying to help Latinos heal from diseases like Parkinson’s. He teamed up with Acadia Pharmaceuticals and StoryCorps nonprofit for the “Yours, Truly” campaign, a bilingual effort to use multicultural storytelling to bring awareness to the non-motor symptoms of Parkinson’s disease. “This campaign is quite important because it really lends to the public an opportunity of being able through storytelling to convey some very important information ...
Declining kidney function is strongly linked to dementia, according to a 10-year study of older adults. This has negative implications for Latinos, who are not only at a high risk for Alzheimer’s and related dementias, but also for chronic kidney disease (CKD). “The kidneys and the brain, both being end organs, are thought to be susceptible to vascular damage due to similar anatomic and hemodynamic features,” according to the researchers. Learn more about what the study found on the link between poor kidney function and dementia, why Latinos are disproportionately affected by these diseases, and how we can help further the research of Latino chronic disease through clinical trials.
What Did the Study Find on Kidney Function and Dementia?
Researchers from the University ...
A San Antonio woman in her 70s underwent South Texas’ first deep brain stimulation (DBS) surgery for Alzheimer’s — one of the first 300 surgeries of its kind in the world — at University Hospital on Nov. 5, 2021. UT Health San Antonio and clinical partner University Health are among 27 clinical trial sites worldwide evaluating the effectiveness of the DBS technique in a clinical trial to treat patients with mild Alzheimer’s disease. DBS is an established, nonpharmaceutical treatment that researchers hope could slow or even halt the progress of this devastating disease. Dr. Alexander Papanastassiou, associate professor of neurosurgery at UT Health San Antonio who sees University Health patients, implanted DBS electrodes during the operation. The surgery is minimally ...
Want to play memory and thinking tests and help millions of families with dementia? The Brain Health Registry can help you do that. Researchers at the University of California San Francisco (UCSF) developed a registry for adults interested in conducting brain tests that can help the future creation of treatments for Alzheimer’s, dementia, Parkinson’s, and other brain disorders. Now, they’re partnering with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio to expand brain health research in the Texas region of the United States, through a partnership called STOP-AD. Learn about the STOP-AD Brain Health Registry, how Alzheimer’s is affecting Latinos, and how clinical trials can help us tackle Alzheimer’s and other ...
Dr. Mirella Díaz-Santos has a personal fight to end Alzheimer’s Disease. Her grandmother was diagnosed with Alzheimer’s when Díaz-Santos was in school. “I needed to know more about how this ‘disease’ can change someone who you love so much. How can it change it completely?” Díaz-Santos said. Díaz-Santos is an assistant professor in residence at University of California at Los Angeles (UCLA) in the department of neurology and psychiatry. She’s also the director of research of the Hispanic Neuropsychiatric Center of Excellence at the Semel Institute for Neuroscience and Human Behavior and is involved with the Women’s Alzheimer’s Movement to bring awareness to Alzheimer’s within the Latino community. Although she’s experienced bias and discrimination ...
